In this paper, we describe the SAR of ozonide carboxylic acid OZ78 (1) as the first part of our search for a trematocidal synthetic peroxide drug development candidate. We found that relatively small structural changes to 1 resulted most commonly in loss of activity against Fasciola hepatica in vivo. A spiroadamantane substructure and acidic functional group (or ester prodrug) were required for activity. Of twenty-six new compounds administered at single 100 mg/kg oral doses to F. hepatica-infected rats, eight had statistically significant worm burden reductions, seven were partially curative, and one (acyl sulfonamide 6) was completely curative and comparable to 1 in flukicidal efficacy. This study also showed that the activity of 1 is peroxide bond-dependent suggesting that its flukicidal efficacy depends upon hemoglobin digestion in F. hepatica.
Although the semisynthetic artemisinins are best known for their powerful antimalarial properties, it is not surprising that they, as well as other peroxidic compounds, possess both antiplasmodial and trematocidal [7] [8] [9] activities, since both plasmodia and several trematodes including Fasciola spp. degrade hemoglobin to generate free heme, a possible target 10 for bioactive peroxides. That the artemisinins and ozonide OZ78 (1) are so much less effective against the nonhemoglobin-degrading intestinal fluke Echinostoma caproni than against hemoglobin-degrading flukes F. hepatica, Clonorchis sinensis, and various schistosome species 9,11-13 supports this hypothesis. 14 Thus, the artemisinins and synthetic peroxides offer excellent starting points 15, 16 for the discovery of broad-spectrum, orally-active trematocidal agents that would minimize drug-resistance and lead to superior treatment and control options.
In this paper, we describe the SAR of ozonide 1 as the first part of our search for a flukicidal synthetic peroxide drug development candidate.
Chemistry. Following the method of Tsandi et al., 17 acyl sulfonamide 6 (Scheme 1) was prepared by reaction of 1 with methansulfonamide in the presence of DMAP and DCC.
Hydrazide 10 was readily prepared by reaction of the corresponding methyl ester 2 with hydrazine. Ozonides 7 and 8, the glycine and taurine conjugates of 1, were synthesized by reaction of HOBt active ester 28 18 with glycine ethyl ester (subsequent ester hydrolysis) and taurine, respectively. Ozonide dicarboxylic acid 14 was synthesized in a five-step sequence (Scheme 2) starting from 29, 19 the Knoevenagel condensation product of 1,4-cyclohexanedione monoethylene ketal and isopropylidene malonate (Meldrum's Acid). 20 Reduction (99%), deketalization (27%), and esterification (37%) afforded diester ketone 30 which underwent Griesbaum coozonolysis 21 with oxime ether 31 22 to afford diester ozonide 32 in 75% yield. The latter was hydrolyzed to afford 14 in high yield. The synthesis of ozonide 16, the monoethyl phosphonic acid isostere of 1, began with the synthesis of ketophosphonate diester 33 (26% yield) (Scheme 3) from 4-(bromomethyl)cyclohexanone in an Arbuzov reaction following the method of Yamagishi et al. 23 4-(Bromomethyl)cyclohexanone, in turn, was obtained by HCl deprotection of the corresponding ethylene ketal 24 26 with methanesulfonic acid followed by alkylation with ethyl bromoacetate in 90% overall yield. Ozonide ester 39, the precursor of ozonide carboxylic acid 18, the trans isomer of 1, was obtained in 21% yield by Griesbaum coozonolysis 21 of oxime ether 38 and 2-adamantanone. With this combination of reaction partners, cis (2) and trans (39) ester ozonides were produced in a ratio of 1:2.5 and 39 was purified by flash column chromatography. In contrast, 2 is the major reaction product in a Griesbaum coozonolysis of oxime ether 31 and keto ester 37. 27 Ozonide carboxylic acids 19 and 20, regioisomers of 1, were both obtained in a straightforward two-step Griesbaum coozonolysis/ester hydrolysis sequence starting from oxime ether 31 and the corresponding keto esters 40 and 42. Unexpectedly, both 41 and 43 were formed with high diastereoselectivity and were isolated as single isomers. Assuming the peroxide bond is axial and the alkyl ester substituent is equatorial, 18 ,27-29 we assigned structures for 19 and 20 as indicated in Scheme 3, although X-ray crystallographic analysis would be required to substantiate this. Fluorinated ozonide acids 23-25 (Scheme 5) were obtained in parallel five to six-step sequences for which the key reaction was a Griesbaum coozonolysis 21 between fluorinated oxime ethers 51, 57, and 61 and keto ester 37 18 to form the corresponding ozonide esters 52, 58, and 62 in low to moderate yields; hydrolysis of the latter yielded 23-25 (62-99%). Ozonide esters 58 and 62 were obtained as single diastereomers and were assigned as cis based on the previously observed 8 diastereoselectivity of the Griesbaum coozonolysis reaction. Ozonide ester 52 was obtained as a 3:1 ratio of diastereomers; as depicted in Scheme 5, the major isomer was assigned as trans, cis based on the diastereoselectivity of similar coozonolysis reactions with other 5-substituted-2-adamantanones. 31 The fluorinated oxime ethers 51, 57, and 61 were obtained in high overall yields by successive treatment of 5-hydroxy-2-adamantanone ethylene ketal (48), 32 6-hydroxy-2-adamantanone ethylene ketal (54), and 2,6-adamantanedione monoethylene ketal (53) 33 with bis(2-methoxyethyl)aminosulfur trifluoride followed by deprotection and condensation with methoxylamine. Table 1 shows efficacy data for a range of acidic, neutral and weak base amide derivatives of 1.
Scheme 3
Of these compounds, the only one with efficacy equal to 1 was acyl sulfonamide 6, although methyl ester 2 and glycine conjugate 7 achieved statistically significant worm burden reductions and partial cures; a 50 mg/kg dose of ethyl ester 3 also produced partial cures. The presence of an acidic functional group was no guarantee of good activity for these ozonides. For example, hydroxamic acid 4, amphoteric acylguanidine 5, and taurine conjugate 8 were either completely inactive or produced marginal decreases in total worm burdens and cured no infected animals.
Unlike 2 and 3, the alkyl ester prodrugs of 1, the primary amide (9), hydrazide (10), and piperazinamide (11) derivatives were inactive or only weakly active and cured no infected rats. The complete loss of efficacy for 27 (Table 3) , the non-peroxidic isostere of 1, shows that the activity of 1 is peroxide bond-dependent. The lack of efficacy for the peroxidic 1,2-dioxolane 26, consistent with our previous data 35 showing that 1,2-dioxolanes have very low to no antimalarial activity, provides additional mechanistic insight. 1,2-Dioxolanes react with Fe(II)
primarily by two-electron vs. one-electron reduction to form inactive diol reaction products rather than carbon-centered radicals, 35 the latter of which are formed by -scission reactions of the initially formed Fe(III) complexed oxy radicals. These -scission reactions are accelerated by the adjacent oxygen atom 41 present in ozonides (1,2,4-trioxolanes), but absent in 1,2-dioxolanes.
Of twenty-six new compounds tested (Tables 1-3) , eight had statistically significant worm burden reductions, seven were partially curative, and one (6) was completely curative.
Compounds that were more effective in reducing worm burdens in the F. hepatica-infected rats also tended to result in partial cures, although ozonide ester 3 (36% worm burden reduction at 50 mg/kg, 2/4 cures) and artesunate (30% worm burden reduction, 2/5 cures) were exceptions.
Given that acyl sulfonamide 6 was the only compound with efficacy equal to that of 1 at the 100 mg/kg dose, it was tested at the lower dose of 50 mg/kg and compared to existing data 12 for 1.
At 50 mg/kg, 1 and 6 reduced worm burdens by 53 and 17%, respectively, but only 1 cured (2/4) the infected rats. Interestingly, previous SAR 18, 26, 29, 42 reveals that acidic ozonides have relatively weak antimalarial activities, so that it may be possible to identify an ozonide with selectivity for inhibition of F. hepatica. However, 1 and 6 are clearly less effective than triclabendazole; at 10 mg/kg, the latter reduced burden reduction by 95% and cured 3/4 infected rats.
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Summary. These data indicate that relatively small structural changes to 1 led, in most cases, to substantial, if not complete, loss of activity against F. hepatica in vivo. A peroxide bond, spiroadamantane substructure, and acidic functional group (or prodrug) were required for activity. Although 1 seems to be an 'optimized' ozonide structure for efficacy against F.
hepatica, its peroxide-dependent activity suggests that, like antimalarial peroxides, 14 its efficacy depends upon hemoglobin digestion in F. hepatica. The mechanistic basis for the superior efficacy of ozonide acids is unclear, but it may derive from a favorable distribution of the unionized forms to the low pH mileau 43 of the trematode gut, the site of hemoglobin digestion.
Indeed, in an electron microscopy study 44 of ex vivo F. hepatica, 1 caused extensive damage to the gut. Investigation of the flukicidal properties of other peroxy heterocycles is in progress.
Experimental Section
General. Melting points are uncorrected. 1 H and 13 C NMR spectra were recorded on a 500 was stirred overnight at rt. After addition of saturated aq. NaHCO 3 to bring the pH to 8, most of the solvents were removed in vacuo and water (100 mL) and ether (100 mL) were added. After separation of the ether layer, the aqueous phase was extracted with ether (3 x 100 mL). The combined organic phases were dried and evaporated to give an oil that was purified by sg Step 2. To a solution of 49 in 2:1 acetone:water (12 mL) was added conc. HCl (4 mL) and the reaction mixture was stirred for 1 h at rt before removal of the solvents in vacuo. CH 2 Cl 2 (6 mL) and water (6 mL)
were added and the two phases were separated followed by extraction of the aq. phase with Step 1. Sodium borohydride (1.11 g, 29.2 mmol) was added portion-wise to a ice-cold solution of 2,6-adamantandione monoethylene ketal (53) 33 (1.74 g, 8.35 mmol) in MeOH (100 mL) at such a rate as to keep the internal temperature below 10 °C. The reaction mixture was allowed to warm to rt and stirred for 24 h. After quenching with water (10 mL), the solvents were removed in vacuo and the residue was partitioned between CH 2 Cl 2 (80 mL) and water (60 mL). After phase separation, the aq. phase was extracted with CH 2 Cl 2 (3 x 40 mL). The combined organic phases were dried over MgSO 4 , filtered, and concentrated in vacuo to afford 6-hydroxy-2-adamantanone monoethylene ketal (54) was added conc. HCl (40 mL) and the reaction mixture was heated to 70 °C gradually. After the disappearance of the starting material as determined by GC-MS (0.5 h), the mixture was cooled to 0 °C and NaHCO 3 was added to adjust the pH to 7. After CH 2 Cl 2 (80 mL) was added to the mixture, the organic layer was separated. The aq. phase was extracted with CH 2 Cl 2 (3 x 50 mL).
The combined organic layers were dried over MgSO 4 , filtered, and concentrated in vacuo to afford 6,6-difluoro-2-adamantanone (60) as a white solid (760 mg, 85% Step 5. To a solution of 62 (322 mg, 0.87 mmol) in EtOH (8 mL) was added a solution of NaOH (104 mg, 2.6 mmol) in water (3 mL).
The mixture was stirred at rt for 4 h and evaporated to give an oil. After the residue was treated with 1 M HCl to lower the pH to 3, the aqueous phase was extracted with CH 2 Cl 2 (3 x 50 mL).
The combined extracts were dried over MgSO 4 at 0 °C was added Et 3 N (4.5 ml, 32 mmol) followed by Et 3 SiOTf (2.54 ml, 12 mmol). The reaction mixture was stirred at rt for 24 h and then diluted with ice-cold hexane (100 mL) and ice-water (100 mL). The organic layer was separated and the aq. layer was extracted with hexane (3 x 100 mL). 
